Related references
Note: Only part of the references are listed.The dispensing of psychotropic medicines to older people before and after they enter residential aged care
Stephanie L. Harrison et al.
MEDICAL JOURNAL OF AUSTRALIA (2020)
First Case of 2019 Novel Coronavirus in the United States
Michelle L. Holshue et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
England and Wales see 20 000 excess deaths in care homes
Talha Burki
LANCET (2020)
Safety of psychotropic medications in people with COVID-19: evidence review and practical recommendations
Giovanni Ostuzzi et al.
BMC MEDICINE (2020)
Preexisting Comorbidities Predicting COVID-19 and Mortality in the UK Biobank Community Cohort
Janice L. Atkins et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2020)
COVID-19-associated coagulopathy: An exploration of mechanisms
Meaghan E. Colling et al.
VASCULAR MEDICINE (2020)
Comorbidities associated with mortality in 31,461 adults with COVID-19 in the United States: A federated electronic medical record analysis
Stephanie L. Harrison et al.
PLOS MEDICINE (2020)
The One-Two Punch of Delirium and Dementia During the COVID-19 Pandemic and Beyond
Sara C. LaHue et al.
FRONTIERS IN NEUROLOGY (2020)
Antipsychotic prescribing to people with dementia during COVID-19
Robert Howard et al.
LANCET NEUROLOGY (2020)
Management of behavioral and psychological symptoms in people with Alzheimer's disease: an international Delphi consensus
Helen C. Kales et al.
INTERNATIONAL PSYCHOGERIATRICS (2019)
Antipsychotic use and risk of life-threatening medical events: umbrella review of observational studies
D. Papola et al.
ACTA PSYCHIATRICA SCANDINAVICA (2019)
Psychotropic Polypharmacy in Patients with Dementia: Prevalence and Predictors
Ane Norgaard et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
The American Psychiatric Association Practice Guideline on the Use of Antipsychotics to Treat Agitation or Psychosis in Patients With Dementia
Victor I. Reus et al.
AMERICAN JOURNAL OF PSYCHIATRY (2016)
Clinical practice guidelines for dementia in Australia
Kate Laver et al.
MEDICAL JOURNAL OF AUSTRALIA (2016)
Antipsychotic prescribing in care homes before and after launch of a national dementia strategy: an observational study in English institutions over a 4-year period
Ala Szczepura et al.
BMJ OPEN (2016)
Management of Neuropsychiatric Symptoms of Dementia in Clinical Settings: Recommendations from a Multidisciplinary Expert Panel
Helen C. Kales et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2014)
Impact of FDA Black Box Advisory on Antipsychotic Medication Use
E. Ray Dorsey et al.
ARCHIVES OF INTERNAL MEDICINE (2010)
Share Paper
